Treatment of the Primary Tumor in Anal Canal Cancers
- PMID: 27889038
- DOI: 10.1016/j.soc.2016.07.003
Treatment of the Primary Tumor in Anal Canal Cancers
Abstract
Radical concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C (MMC) remains the standard of care for squamous cell carcinoma of the anus. Phase III trials over 2 decades have used combined radiation doses of 50 to 60 Gy with concurrent fluoropyrimidines, MMC, or cisplatin in various doses and schedules. Modern radiotherapy techniques allow the production of highly conformal plans, decreasing radiation doses to the organs at risk and ensuring a shorter overall treatment time without the need for treatment breaks. These techniques offer the potential to improve compliance and even escalate doses of radiation.
Keywords: Anal carcinoma; Chemoradiation; Chemotherapy; Combined modality; Immunotherapy; Local recurrence; Radiotherapy; Squamous cell carcinoma of the anus.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
[Management of locally advanced anal canal carcinoma with modulated arctherapy and concurrent chemotherapy].Cancer Radiother. 2015 Apr;19(2):127-38. doi: 10.1016/j.canrad.2014.12.005. Epub 2015 Mar 12. Cancer Radiother. 2015. PMID: 25770884 French.
-
Outcomes after intensity-modulated compared with 3-dimensional conformal radiotherapy with chemotherapy for squamous cell carcinoma of the anal canal.Curr Oncol. 2019 Aug;26(4):e515-e521. doi: 10.3747/co.26.4311. Epub 2019 Aug 1. Curr Oncol. 2019. PMID: 31548820 Free PMC article.
-
Anal cancer - What is the optimum chemoradiotherapy?Best Pract Res Clin Gastroenterol. 2016 Aug;30(4):641-53. doi: 10.1016/j.bpg.2016.06.005. Epub 2016 Jun 30. Best Pract Res Clin Gastroenterol. 2016. PMID: 27644911 Review.
-
Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal.Cancer. 2011 Aug 1;117(15):3342-51. doi: 10.1002/cncr.25901. Epub 2011 Feb 1. Cancer. 2011. PMID: 21287530
-
Randomized Clinical Trials in Localized Anal Cancer.Surg Oncol Clin N Am. 2017 Oct;26(4):705-718. doi: 10.1016/j.soc.2017.05.009. Epub 2017 Aug 18. Surg Oncol Clin N Am. 2017. PMID: 28923226 Review.
Cited by
-
A nomogram for predicting survival in patients with advanced (stage III/IV) pancreatic body tail cancer: a SEER-based study.BMC Gastroenterol. 2022 Jun 3;22(1):279. doi: 10.1186/s12876-022-02362-2. BMC Gastroenterol. 2022. PMID: 35658912 Free PMC article.
-
VITAL phase 2 study: Upfront 5-fluorouracil, mitomycin-C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09-02).Cancer Med. 2020 Feb;9(3):1008-1016. doi: 10.1002/cam4.2722. Epub 2019 Dec 18. Cancer Med. 2020. PMID: 31851776 Free PMC article. Clinical Trial.
-
Development and Validation of Prognostic Survival Nomograms for Patients with Anal Canal Cancer: A SEER-Based Study.Int J Gen Med. 2021 Dec 20;14:10065-10081. doi: 10.2147/IJGM.S346381. eCollection 2021. Int J Gen Med. 2021. PMID: 34984027 Free PMC article.
-
Complex Reconstruction with Flaps After Abdominoperineal Resection and Groin Dissection for Anal Squamous Cell Carcinoma: A Difficult Case Involving Many Specialities.Am J Case Rep. 2018 Jan 17;19:61-67. doi: 10.12659/ajcr.906818. Am J Case Rep. 2018. PMID: 29339717 Free PMC article.
-
Risk-adjusted chemoradiation according to human papilloma viral status for anal cancer: a pilot study.Front Oncol. 2023 Jun 29;13:1183854. doi: 10.3389/fonc.2023.1183854. eCollection 2023. Front Oncol. 2023. PMID: 37456246 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
